ADENTRA (ADEN) Q3 2024 earnings summary

Executive summary

• Q3 2024 sales rose 1.8% to $568.8 million, driven by the Woolf acquisition's $31.4 million contribution, offsetting a 3.7% organic sales decline.

• Net income increased 28.7% to $10.4 million, with basic EPS up 16.7% to $0.42.

• Gross margin improved to 21.3%, supported by higher-margin acquisitions, product mix, and strategic initiatives.

• Adjusted EBITDA fell 7.2% year-over-year to $48 million due to increased operating expenses and softer sales.

• Strong cash flow of $66 million supported the Woolf acquisition and maintained a leverage ratio of 2.5x.

Financial highlights

• Gross profit was $121.4 million, up 2.6% year-over-year, with a gross margin of 21.3%.

• Operating expenses decreased by $4.2 million to $96.7 million, mainly due to the non-recurrence of $15.5 million in trade duties.

• US sales grew by $8.4 million to $524.9 million, despite a 3% price and 2% volume decrease.

• Canadian sales increased by CAD 3.3 million to CAD 59.9 million, with a 10% volume increase and 4% price decrease.

• Operating cash flow before working capital changes increased to $38.6 million from $25.9 million.

Outlook and guidance

• Q4 2024 adjusted EBITDA anticipated to align closely with Q4 2023, despite affordability pressures and slow interest rate reductions.

• Expect solid cash flow in Q4 2024, supporting continued debt repayment and further acquisitions.

• Destination 2028 plan targets $800 million in additional run-rate revenue via acquisitions by 2028, 10%+ EBITDA margin, and 12%+ ROIC.

• Forecasts indicate improving building market conditions in the second half of 2025 and beyond, driven by expected interest rate reductions and strong housing fundamentals.